Seeking Alpha

The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and...

The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and above. The vaccine is the first one for the illness that's produced using cultured animal cells rather than fertilized chicken eggs. That should allow mass production to begin faster if there's a pandemic.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector